Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Recruiting

Phase 3

Radiotherapy & ChemotherapyTesting the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT04248452

Conditions

Clinical Stage IV Esophageal Adenocarcinoma AJCC v8

Clinical Stage IV Gastric Cancer AJCC v8

Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8

Clinical Stage IVA Gastric Cancer AJCC v8

Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

Fluorouracil

Leucovorin

Leucovorin Calcium

Oxaliplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2024-11-05.